what is congenital cholesteatoma

Reading File
Finding Sources
Searching Images

congenital cholesteatoma ear middle ear

This multi-modal diagnostic image panel demonstrates a congenital middle ear cholesteatoma (CMEC) in an 11-year-old patient. Image (a) is an axial Cone Beam CT (CBCT) showing a well-defined, rounded soft tissue mass (asterisk) in the anterior-superior quadrant of the middle ear, extending medially to the malleus handle (arrowhead). Images (b-e) provide Magnetic Resonance Imaging (MRI) correlations of the same lesion (arrowheads). The lesion exhibits pathognomonic signal characteristics: high signal intensity on non-echo planar diffusion-weighted imaging (DWI b1000, image b) and low signal on the corresponding Apparent Diffusion Coefficient (ADC) map (image c), confirming true restricted diffusion. Coronal T2-weighted (d) and T1-weighted (e) images show intermediate and low signal intensities, respectively. This combination of CT morphology and MRI diffusion restriction is essential for differentiating cholesteatoma from other middle ear pathologies like cholesterol granuloma or inflammatory tissue. The case illustrates the standard radiological protocol for evaluating conductive hearing loss and localizing intratympanic masses in pediatric patients.

This multi-modal diagnostic image panel demonstrates a congenital middle ear cholesteatoma (CMEC) in an 11-year-old patient. Image (a) is an axial Cone Beam CT (CBCT) showing a well-defined, rounded soft tissue mass (asterisk) in the anterior-superior quadrant of the middle ear, extending medially to the malleus handle (arrowhead). Images (b-e) provide Magnetic Resonance Imaging (MRI) correlations of the same lesion (arrowheads). The lesion exhibits pathognomonic signal characteristics: high signal intensity on non-echo planar diffusion-weighted imaging (DWI b1000, image b) and low signal on the corresponding Apparent Diffusion Coefficient (ADC) map (image c), confirming true restricted diffusion. Coronal T2-weighted (d) and T1-weighted (e) images show intermediate and low signal intensities, respectively. This combination of CT morphology and MRI diffusion restriction is essential for differentiating cholesteatoma from other middle ear pathologies like cholesterol granuloma or inflammatory tissue. The case illustrates the standard radiological protocol for evaluating conductive hearing loss and localizing intratympanic masses in pediatric patients.

A multi-panel clinical figure documenting a case of Stage III Congenital Middle Ear Cholesteatoma (CMEC). Panel A presents an endoscopic view of the left tympanic membrane, showing a prominent, whitish, opalescent mass localized behind the eardrum, involving multiple quadrants. Panels B and C are high-resolution CT scans of the temporal bone in coronal and axial planes, respectively, demonstrating a soft tissue density filling the middle ear cavity with associated erosion or impairment of the ossicular chain, while the mastoid air cells remain well-pneumatized and uninvolved. Panel D shows an intraoperative view following cholesteatoma excision, highlighting a Total Ossicular Replacement Prosthesis (TORP) placed for hearing reconstruction due to an absent stapes superstructure. Panel E displays a postoperative audiogram showing mild conductive hearing loss with a 10 dB air-bone gap, indicating successful functional reconstruction. This composite serves as an educational tool for the diagnosis, surgical management via endoscopic ear surgery (EES), and functional outcomes of pediatric middle ear cholesteatoma.

A multi-panel clinical figure documenting a case of Stage III Congenital Middle Ear Cholesteatoma (CMEC). Panel A presents an endoscopic view of the left tympanic membrane, showing a prominent, whitish, opalescent mass localized behind the eardrum, involving multiple quadrants. Panels B and C are high-resolution CT scans of the temporal bone in coronal and axial planes, respectively, demonstrating a soft tissue density filling the middle ear cavity with associated erosion or impairment of the ossicular chain, while the mastoid air cells remain well-pneumatized and uninvolved. Panel D shows an intraoperative view following cholesteatoma excision, highlighting a Total Ossicular Replacement Prosthesis (TORP) placed for hearing reconstruction due to an absent stapes superstructure. Panel E displays a postoperative audiogram showing mild conductive hearing loss with a 10 dB air-bone gap, indicating successful functional reconstruction. This composite serves as an educational tool for the diagnosis, surgical management via endoscopic ear surgery (EES), and functional outcomes of pediatric middle ear cholesteatoma.

This composite clinical figure illustrates the diagnostic and surgical characteristics of a congenital cholesteatoma in a pediatric patient. Panel A shows an otoscopic view of a pearly, white, spherical mass situated behind an intact, translucent tympanic membrane in the anterior-superior quadrant. Panel B provides an axial non-contrast computed tomography (CT) scan of the temporal bone, identifying a localized soft tissue density within the middle ear cavity without evidence of significant ossicular erosion. Panel C displays the intraoperative finding via a retroauricular approach, revealing the intact spherical keratinous cyst before excision. Panel D shows the gross pathology of the excised specimen, a small pearl-like mass approximately 5mm in diameter (scale bar provided). The figure highlights the classic presentation of congenital cholesteatoma as a 'keratin pearl' in a child with no prior history of ear discharge, surgery, or tympanic membrane perforation. This content is relevant for otolaryngology education regarding middle ear pathologies and surgical management.

This composite clinical figure illustrates the diagnostic and surgical characteristics of a congenital cholesteatoma in a pediatric patient. Panel A shows an otoscopic view of a pearly, white, spherical mass situated behind an intact, translucent tympanic membrane in the anterior-superior quadrant. Panel B provides an axial non-contrast computed tomography (CT) scan of the temporal bone, identifying a localized soft tissue density within the middle ear cavity without evidence of significant ossicular erosion. Panel C displays the intraoperative finding via a retroauricular approach, revealing the intact spherical keratinous cyst before excision. Panel D shows the gross pathology of the excised specimen, a small pearl-like mass approximately 5mm in diameter (scale bar provided). The figure highlights the classic presentation of congenital cholesteatoma as a 'keratin pearl' in a child with no prior history of ear discharge, surgery, or tympanic membrane perforation. This content is relevant for otolaryngology education regarding middle ear pathologies and surgical management.

A multi-panel clinical figure documenting a case of Stage II Congenital Middle Ear Cholesteatoma (CMEC). Panel A presents a preoperative audiogram showing mild conductive hearing loss. Panel B is an endoscopic view of the right tympanic membrane, revealing a characteristic opaque, white mass located behind the posterior-superior and inferior quadrants, accompanied by surface keratinous debris. Panels C and D are high-resolution computed tomography (CT) scans of the temporal bone in coronal and axial views, respectively. These demonstrate a soft-tissue density localized within the middle ear cavity without evidence of mastoid air cell involvement or significant bony erosion. Panel E shows an intraoperative endoscopic view after complete surgical excision, confirming an intact ossicular chain. This compilation illustrates the diagnostic triad of pediatric CMEC: audiometric assessment, characteristic otoscopic white reflex (leukocoria of the ear), and radiological localization for surgical planning.

A multi-panel clinical figure documenting a case of Stage II Congenital Middle Ear Cholesteatoma (CMEC). Panel A presents a preoperative audiogram showing mild conductive hearing loss. Panel B is an endoscopic view of the right tympanic membrane, revealing a characteristic opaque, white mass located behind the posterior-superior and inferior quadrants, accompanied by surface keratinous debris. Panels C and D are high-resolution computed tomography (CT) scans of the temporal bone in coronal and axial views, respectively. These demonstrate a soft-tissue density localized within the middle ear cavity without evidence of mastoid air cell involvement or significant bony erosion. Panel E shows an intraoperative endoscopic view after complete surgical excision, confirming an intact ossicular chain. This compilation illustrates the diagnostic triad of pediatric CMEC: audiometric assessment, characteristic otoscopic white reflex (leukocoria of the ear), and radiological localization for surgical planning.

Searching PubMed

"congenital cholesteatoma"[MeSH Terms]

Reading File
Reading File
Reading File
I now have rich content from three authoritative textbooks. Let me compile the full answer.

Congenital Cholesteatoma

Definition

A congenital cholesteatoma (CC) is an expanding cystic mass of keratinizing squamous epithelium located medially to an intact tympanic membrane, assumed to be present at birth but usually diagnosed during infancy or early childhood in patients with no prior history of otorrhea, tympanic membrane perforation, or ear surgery. It appears as a white, pearl-like cyst behind the eardrum.
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 4511
  • Cummings Otolaryngology, p. 728

Pathogenesis / Embryology

The most widely accepted theory is persistence of epidermoid cell rests (embryonic epithelial remnants) in the anterior epitympanum. These rests normally regress by approximately 33 weeks' gestation; if they persist and proliferate, squamous epithelium accumulates in the middle ear space, forming the cholesteatoma. The cells may also originate from the meatal plug displaced during canalization of the external acoustic meatus.
  • The Developing Human - Clinically Oriented Embryology, p. 2580
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 4517
Most CCs arise from the anterior middle ear, though they can be found posteriorly or elsewhere in the temporal bone, suggesting possible alternative cell rests or pathogenic mechanisms.

Anatomic Classification

Congenital cholesteatomas of the temporal bone are divided into four anatomic groups:
GroupLocation
1Middle ear (most common)
2Perigeniculate area (around facial nerve genu)
3Petrous apex
4Cerebellopontine angle
  • Cummings Otolaryngology, p. 728

Clinical Features

Middle ear CC:
  • White, opalescent mass behind an intact tympanic membrane (the classic "keratin pearl")
  • Conductive hearing loss (usually the presenting complaint)
  • ~50% of patients present with recurrent otitis media
  • May fistulize through the tympanic membrane if untreated
Perigeniculate / Petrous apex CC:
  • Facial nerve paralysis (insidious, progressive)
  • Sensorineural hearing loss or vestibular dysfunction from labyrinthine/IAC erosion
  • May expand dramatically before producing symptoms
Note: Late diagnosis is possible because early lesions are often asymptomatic. An extensive CC can become infected, causing tympanic membrane breakdown -- making it hard to distinguish from acquired cholesteatoma in an older child.
  • Cummings Otolaryngology, p. 733-735

Staging (Potsic System)

StageDescription
ISingle quadrant; no ossicular involvement or mastoid extension
IIMultiple quadrants; no ossicular involvement or mastoid extension
IIIOssicular involvement (erosion/removal); no mastoid extension
IVMastoid extension (regardless of other findings)
Stage at presentation directly correlates with risk of residual disease post-surgery and degree of initial hearing loss.
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 4542-4557

Diagnostic Evaluation

  • Otoscopy: White, pearly mass behind an intact tympanic membrane
  • High-resolution CT (temporal bone): Demonstrates soft tissue density in the middle ear; identifies ossicular erosion and bony destruction
  • MRI: CC shows slightly higher signal than CSF on T1, and moderately high signal on T2-weighted images. Diffusion-weighted imaging (DWI) shows restricted diffusion (bright on DWI, low on ADC map) -- key for differentiating from cholesterol granuloma (which is bright on both T1 and T2) or arachnoid cysts
  • Cummings Otolaryngology, p. 740
Here is a characteristic imaging example of a congenital middle ear cholesteatoma:
Congenital middle ear cholesteatoma - CT and MRI panel showing classic restricted diffusion on DWI
CT and MRI panel of congenital middle ear cholesteatoma: the axial CBCT (a) shows a well-defined soft tissue mass in the anterior-superior quadrant; DWI (b) shows high signal and ADC (c) shows low signal confirming restricted diffusion.
Classic otoscopic and surgical appearance of congenital cholesteatoma
Otoscopic view showing a pearly-white mass behind an intact tympanic membrane (Panel A), CT scan (Panel B), intraoperative view (Panel C), and excised keratin pearl specimen (Panel D).

Surgical Management

  • Goal: Complete removal of the cholesteatoma matrix or permanent exteriorization
  • Isolated middle ear CC: Can be removed transtympanically with full visualization of the extent of the lesion, especially on the medial aspect of the eardrum
  • Ossicular erosion: Standard middle ear reconstructive techniques (ossiculoplasty, TORP/PORP)
  • Perigeniculate / Petrous apex CC: Approaches include middle cranial fossa, transotic, or transsphenoidal, depending on hearing status and location
  • Cummings Otolaryngology, p. 745

Key Distinguishing Features (vs. Acquired Cholesteatoma)

FeatureCongenitalAcquired
Tympanic membraneIntactPerforated or retraction pocket
History of otorrheaAbsentUsually present
Prior ear surgery/AOMAbsent (by definition)Often present
Age at presentationInfancy/early childhoodAny age
LocationAnterior middle ear most commonPosterior/superior most common
No recent systematic reviews or meta-analyses on congenital cholesteatoma were found in PubMed for the past 2 years, so the textbook evidence above represents the current standard of knowledge.

Can you tell me why there is a labyrinthitis or sensorineural hearing loss in cases of Com?

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Reading File
I have comprehensive, well-sourced information from four textbooks. Here is the full answer:

Why Labyrinthitis and SNHL Occur in COM

In chronic otitis media (COM) -- especially the unsafe/atticoantral type with cholesteatoma -- the inner ear is at risk through several distinct mechanisms. These are best understood by separating the routes of spread from the resulting inner ear injury.

1. Labyrinthine Fistula (Most Common Mechanism)

The most frequent path to inner ear damage in COM is erosion of the endochondral bone overlying the semicircular canals, creating a labyrinthine fistula. This occurs in approximately 7-13% of COM cases with cholesteatoma.
Why the lateral semicircular canal is most vulnerable:
  • It is the most prominent structure in the aditus ad antrum
  • It lies directly in the path of an enlarging posterior-superior cholesteatoma
  • The cholesteatoma matrix produces pro-inflammatory cytokines that activate osteoclasts, causing progressive demineralization and bone resorption
The sequence is:
  1. Cholesteatoma matrix contacts the endochondral bone of the labyrinth
  2. Osteoclast-mediated bone erosion -- the bone first demineralizes, then disappears
  3. Intraoperatively, a thin residual bone layer appears as a "blue line" parallel to the canal lumen
  4. Eventually, only the endosteum (and sometimes just perilymph) separates the middle ear from the inner ear
"Labyrinthine fistula represents an erosive loss of the endochondral bone that overlies the semicircular canals without loss of perilymph... This loss of the overlying protective bone allows pressure or mass-induced motion of the underlying endosteum, perilymph, and, by contiguity, the endolymphatic compartment, which evokes vestibular and sometimes auditory symptoms."
  • Cummings Otolaryngology, p. 2307
The typical clinical result is vestibular symptoms (vertigo, especially on pressure changes -- positive fistula test), but if the cochlea is eroded instead, SNHL results.
Below is a histological section showing a labyrinthine fistula from active mucosal COM -- note that only the endosteum separates the perilymphatic space from the middle ear:
Histological section of labyrinthine fistula in COM showing ampulla, crista, and fistula site with only endosteum remaining
High-power temporal bone section: bone over the lateral semicircular canal has been resorbed by COM, leaving only the endosteum to separate the middle ear from the perilymphatic space. (Scott-Brown's Vol 2, Fig. 83.8)

2. Spread of Infection: Serous vs. Suppurative Labyrinthitis

Once the fistula is established, infection can spread into the labyrinth. There are two grades of severity:
TypeMechanismEffect on Inner Ear
Serous labyrinthitisBacterial toxins and inflammatory mediators diffuse across the intact endosteum or round window membrane into the perilymph, without actual bacterial invasionReversible or partial SNHL; vertigo
Suppurative labyrinthitisFrank bacterial invasion of the labyrinth, usually via the fistula or round windowIrreversible, profound SNHL; total vestibular loss (dead labyrinth)
The spread is most often associated with the bone-eroding atticoantral type of COM. Symptoms include vertigo, pain, nausea/vomiting, hearing loss, and 3rd-degree spontaneous nystagmus beating toward the non-diseased (contralateral) ear.
  • Shambaugh Surgery of the Ear, p. 5672-5675
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 915-940

3. Diffusion of Ototoxic Substances Through the Round Window Membrane

Even without a gross fistula, bacterial toxins and inflammatory mediators from the infected middle ear can diffuse across the round window membrane into the perilymph. This is a well-documented cause of SNHL in COM:
  • Chole and Chiu demonstrated loss of cochlear hair cell stereocilia in animals with experimental cholesteatomas, with or without infection
  • McGinn and Chole showed hair cell loss in areas of the cochlea subjacent to areas of bone erosion, suggesting ototoxic substances may traverse the bony cochlear wall directly
  • Meyerhoff et al. found that 17.9% of temporal bones with COM showed histologic evidence of labyrinthitis
  • Vartiainen and Karjalainen compared 874 chronically infected ears to 609 controls and found significantly worse bone conduction (cochlear function surrogate) in infected ears -- ears with cholesteatoma were worse than those without
"The destructive effects of an expanding cholesteatoma within the middle ear or mastoid and concomitant chronic infection are not limited to the bony structures of the temporal bone."
  • Cummings Otolaryngology, p. 1191
The cellular target within the cochlea includes:
  • Cochlear hair cells (outer > inner)
  • Spiral ganglion cells
  • Stria vascularis -- type I fibrocytes in the spiral ligament express NF-κB, which alters ion channel function and impairs endocochlear potential
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 918-923

Summary of Mechanisms

COM (cholesteatoma/infection)
        |
        ├── Bone erosion → Labyrinthine fistula (lateral SCC most common)
        │           ├── Pressure on endosteum → Vestibular symptoms
        │           └── Bacterial invasion → Suppurative labyrinthitis → Dead labyrinth
        │
        ├── Toxin/mediator diffusion → Round window membrane
        │           └── Serous labyrinthitis → Cochlear hair cell damage → SNHL
        │
        └── Direct bony cochlear wall traversal by ototoxic substances
                    └── Hair cell loss → SNHL

Clinical Note on Surgical Management of Labyrinthine Fistula

This is controversial. When cholesteatoma matrix covers a fistula:
  • Removing the matrix risks perilymph loss and SNHL (~10% risk of SNHL in reported series)
  • Leaving the matrix intact at first surgery (canal wall up or canal wall down) and removing it at a second stage -- when the matrix has walled off into a small cyst -- results in SNHL avoidance in >96% of cases
  • Shambaugh Surgery of the Ear, p. 5651-5663

Can you please explain me how cholestatoma spreads and what is the physiology of destruction?

Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Loading Image
Loading Image
Searching Images

cholesteatoma spread pathway middle ear mastoid ossicular erosion diagram

This diagnostic image is a coronal Computed Tomography (CT) scan of the temporal bone, specifically the middle ear and surrounding mastoid structures. The scan reveals a large, non-enhancing soft tissue density within the middle ear cavity and epitympanum, characteristic of a cholesteatoma. Key pathological findings include the significant erosion and partial lysis of the ossicular chain, involving the malleus and incus. There is also evident blunting and erosion of the scutum (the lateral wall of the attic), a classic radiographic sign of an acquired cholesteatoma. The bony labyrinth, including the cochlea and semicircular canals, appears relatively spared. The tegmen tympani remains intact without obvious intracranial extension. This image demonstrates the destructive nature of middle ear cholesteatoma on the conductive hearing apparatus and its impact on the local bony architecture of the temporal bone, serving as a primary tool for preoperative planning in otolaryngology.

This diagnostic image is a coronal Computed Tomography (CT) scan of the temporal bone, specifically the middle ear and surrounding mastoid structures. The scan reveals a large, non-enhancing soft tissue density within the middle ear cavity and epitympanum, characteristic of a cholesteatoma. Key pathological findings include the significant erosion and partial lysis of the ossicular chain, involving the malleus and incus. There is also evident blunting and erosion of the scutum (the lateral wall of the attic), a classic radiographic sign of an acquired cholesteatoma. The bony labyrinth, including the cochlea and semicircular canals, appears relatively spared. The tegmen tympani remains intact without obvious intracranial extension. This image demonstrates the destructive nature of middle ear cholesteatoma on the conductive hearing apparatus and its impact on the local bony architecture of the temporal bone, serving as a primary tool for preoperative planning in otolaryngology.

This diagnostic image is a coronal Computed Tomography (CT) scan of the temporal bones focusing on the middle ear and mastoid air cell systems. The scan demonstrates significant bilateral pathology characterized by extensive bony erosion and the loss of normal mastoid air cell septation, a condition described as automastoidectomy. The middle ear cavities and enlarged mastoid regions are opacified by heterogeneous soft tissue density material, consistent with congenital cholesteatoma. Key visible landmarks include the ossicular chain, which appears indistinct or eroded, and the tegmen tympani. On the right side, measurements are visible indicating clinical assessment of the bony structures. The anatomical context relates to a rare case of a first branchial cleft fistula opening into the middle ear through the zygomatic root. This visual is significant for otolaryngology and pediatric radiology, illustrating the advanced bony remodeling and middle ear obliteration associated with congenital ear malformations and chronic cholesteatoma.

This diagnostic image is a coronal Computed Tomography (CT) scan of the temporal bones focusing on the middle ear and mastoid air cell systems. The scan demonstrates significant bilateral pathology characterized by extensive bony erosion and the loss of normal mastoid air cell septation, a condition described as automastoidectomy. The middle ear cavities and enlarged mastoid regions are opacified by heterogeneous soft tissue density material, consistent with congenital cholesteatoma. Key visible landmarks include the ossicular chain, which appears indistinct or eroded, and the tegmen tympani. On the right side, measurements are visible indicating clinical assessment of the bony structures. The anatomical context relates to a rare case of a first branchial cleft fistula opening into the middle ear through the zygomatic root. This visual is significant for otolaryngology and pediatric radiology, illustrating the advanced bony remodeling and middle ear obliteration associated with congenital ear malformations and chronic cholesteatoma.

This composite of high-resolution computerized tomography (HRCT) axial scans of the temporal bone demonstrates a progressive classification of middle ear cholesteatoma based on bone destruction. (A) Baseline normal anatomy showing an intact ossicular chain (malleus, incus, and stapes) and a well-defined sigmoid sinus bone plate. (B) Grade (+) showing early soft tissue opacification without definitive ossicular erosion. (C) Grade (++) demonstrating clear destruction of the malleus and/or incus (indicated by arrow). (D) Grade (+++) showing advanced erosion involving the incus and stapes. (E) Grade (++++) exhibiting the most extensive destruction, involving the complete ossicular chain, mastoid tegmen, and/or the sigmoid sinus bone plate (indicated by arrow). Key visual indicators of pathology across the series include increased radiolucency, irregular bone margins, and loss of structural integrity of the auditory ossicles and mastoid air cells. This visual scale serves as a diagnostic tool for assessing the severity of cholesteatoma invasion and its correlation with clinical outcomes such as hearing loss.

This composite of high-resolution computerized tomography (HRCT) axial scans of the temporal bone demonstrates a progressive classification of middle ear cholesteatoma based on bone destruction. (A) Baseline normal anatomy showing an intact ossicular chain (malleus, incus, and stapes) and a well-defined sigmoid sinus bone plate. (B) Grade (+) showing early soft tissue opacification without definitive ossicular erosion. (C) Grade (++) demonstrating clear destruction of the malleus and/or incus (indicated by arrow). (D) Grade (+++) showing advanced erosion involving the incus and stapes. (E) Grade (++++) exhibiting the most extensive destruction, involving the complete ossicular chain, mastoid tegmen, and/or the sigmoid sinus bone plate (indicated by arrow). Key visual indicators of pathology across the series include increased radiolucency, irregular bone margins, and loss of structural integrity of the auditory ossicles and mastoid air cells. This visual scale serves as a diagnostic tool for assessing the severity of cholesteatoma invasion and its correlation with clinical outcomes such as hearing loss.

I now have excellent textbook content, molecular diagrams, and electron micrographs to build a thorough answer. Here it is:

How Cholesteatoma Spreads and Destroys - The Full Picture


Part 1: Structure of the Lesion (What Is Spreading)

A cholesteatoma has three layers:
LayerDescription
MatrixKeratinizing squamous epithelium - the "skin" lining the sac; this is the actively destructive layer
PerimatrixSubepithelial connective tissue richly infiltrated with inflammatory cells (fibroblasts, macrophages, T-cells, osteoclast precursors)
Keratin debrisDead, desquamated cells that accumulate inside the sac, expanding it under pressure
The matrix behaves like skin -- it constantly sheds keratin inward. As the debris accumulates, the sac expands and the matrix is pushed outward against bone, eroding whatever it contacts.
  • Cummings Otolaryngology, p. 1186

Part 2: Routes and Direction of Spread

Spread follows paths of least resistance -- air cell tracts, natural bony dehiscences, and anatomical spaces. The direction depends on where the cholesteatoma originates.

Pars Flaccida (Attic/Epitympanic) Cholesteatoma - Most Common

This is the classic "unsafe" COM pattern:
  1. Retraction pocket forms in the pars flaccida → invaginates into the Prussak space (lateral epitympanic recess)
  2. Keratin accumulates → sac expands medially
  3. Scutum (lateral attic wall) is eroded first
  4. Ossicles are displaced medially and eroded - the long process of the incus is the most frequently destroyed ossicle
  5. Spreads posteriorly into the aditus ad antrummastoid antrum → mastoid air cells (automastoidectomy)
  6. Can track medially to the tegmen (roof), causing tegmen dehiscence and dural exposure
  7. Can erode the lateral semicircular canal (labyrinthine fistula)
  8. Can track along the fallopian canal → facial nerve involvement

Pars Tensa (Posterosuperior) Cholesteatoma

  1. Arises from posterior or posterosuperior marginal perforation
  2. Grows medial to the ossicular chain (unlike pars flaccida type which is lateral to ossicles)
  3. Erodes the posterior lateral attic wall and posterosuperior EAC wall
  4. Tends to erode the stapes superstructure and long process of incus early
  5. Higher tendency for inner ear erosion compared to pars flaccida type
  • Shambaugh Surgery of the Ear, p. 2069-2083
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 767-793
Here is a CT scan showing scutum erosion and medial ossicular displacement in a pars flaccida cholesteatoma:
Coronal CT showing cholesteatoma eroding the scutum with ossicular involvement
And this CT series illustrates progressive grades of bony destruction from early ossicular erosion to complete demolition of the ossicular chain and mastoid tegmen:
HRCT series showing graded cholesteatoma bone destruction from early ossicular erosion to complete mastoid and tegmen involvement

Part 3: The Physiology of Bone Destruction

This is the most important part of the question and involves molecular, cellular, and enzymatic mechanisms working together.

Step 1: The Old (Wrong) Theory - Pressure Necrosis

Early 20th century clinicians believed the expanding sac simply crushed bone. This was abandoned when direct measurements showed cholesteatoma exerts only 1.3-11.9 mm Hg of pressure -- far below the capillary perfusion pressure (~25 mm Hg) needed to cause necrosis. Pressure alone cannot account for the extent or pattern of bone destruction seen clinically.
  • Cummings Otolaryngology, p. 1133

Step 2: Osteoclast-Mediated Bone Resorption (The Core Mechanism)

The only cell capable of truly resorbing bone is the multinucleated osteoclast. Multiple human temporal bone and experimental studies have confirmed that osteoclastic resorption is the primary destructive mechanism in cholesteatoma.
How osteoclasts work at the resorptive zone:
  • Osteoclasts form a tight sealing zone against bone
  • They create a ruffled border -- a highly folded membrane that dramatically increases surface area
  • The space beneath the ruffled border is acidified (pH 4.0)
  • Acid phosphatase dissolves the mineral (hydroxyapatite) phase of bone
  • Acid proteases (cathepsin-like enzymes) and collagenase dissolve the organic collagen matrix
  • The resulting resorption lacunae progressively deepen, eating through bone
The electron micrograph below from Cummings shows multinucleated osteoclasts actively resorbing bone directly beneath cholesteatoma matrix (A), and the ruffled border (RB) with its acid protease-filled vacuoles (V) at ultrastructural level (B):
Transmission electron micrograph: multinucleated osteoclasts actively resorbing bone under cholesteatoma matrix (A); ruffled border with acid protease vacuoles at the resorptive zone (B)

Step 3: The RANK/RANKL Signaling Cascade

The key molecular question is: what recruits and activates osteoclasts?
The answer is the RANK-RANKL-OPG axis:
  • The cholesteatoma matrix and surrounding bacterial products (LPS from biofilm) trigger inflammation
  • This activates T cells, macrophages, and stromal cells in the perimatrix
  • These cells express RANKL (Receptor Activator of NF-κB Ligand) on their surface
  • RANKL binds to RANK receptors on osteoclast precursors (bone marrow-derived monocytes)
  • This drives osteoclastogenesis -- differentiation of precursors into active multinucleated osteoclasts
  • M-CSF (macrophage colony-stimulating factor) potentiates this process
  • Osteoprotegerin (OPG) is the natural decoy receptor that would normally inhibit RANKL -- in cholesteatoma, OPG is overwhelmed by the pro-inflammatory state
  • Pro-inflammatory cytokines TNF-α, IL-1, IL-6 further amplify osteoclast activation
This entire molecular cascade is illustrated beautifully in the diagram below from Cummings:
Cummings molecular diagram: Cholesteatoma + bacterial biofilm/LPS → inflammation → TNF-α, IL-1, IL-6 from macrophages and T cells → RANKL on osteoblasts/T cells → RANK on osteoclast precursors → active osteoclasts → RESORPTIVE ZONE on bone
Fig. 140.17 from Cummings Otolaryngology: The RANK/RANKL pathway driving osteoclastogenesis in cholesteatoma.

Step 4: Matrix Metalloproteinases (MMPs)

In addition to osteoclast enzymes, the cholesteatoma epithelium itself secretes:
  • MMPs 1, 2, 3, and 9 -- expressed in basal and suprabasal cell layers of the matrix
  • Neutrophil collagenase -- found throughout the epithelium and granulation tissue
  • TIMP-1 (tissue inhibitor of MMPs) is present only in tiny amounts in granulation tissue -- meaning the inhibitory check is essentially absent
How MMPs contribute:
  • MMPs degrade the extracellular matrix around bone (collagen, fibronectin, gelatin)
  • Neutral collagenase specifically degrades the osteoid (unmineralized collagen) surface of bone, stripping away the organic layer and directly exposing mineralized bone to osteoclastic attack
  • This "primes" the bone surface for osteoclast binding and resorption
  • Cummings Otolaryngology, p. 1147-1150

Step 5: Keratin Debris as a Direct Inflammatory Trigger

When the sac ruptures or keratin extrudes into the subepithelial space:
  • Keratin itself triggers a foreign body granuloma response
  • This elicits further macrophage and inflammatory cell infiltration
  • Which amplifies the osteoclastic response locally
This creates a self-perpetuating cycle: more keratin → more inflammation → more osteoclasts → more bone destruction → more space for sac expansion → more keratin production.

Part 4: Why Endochondral Bone Is More Resistant

The otic capsule (surrounding the cochlea and semicircular canals) is made of endochondral bone -- denser, more compact, and metabolically less active than the intramembranous bone of the middle ear walls and mastoid. The osteoclastogenic signaling pathways are less effective in this bone type, which is why:
  • The mastoid air cells and middle ear walls are destroyed early
  • The otic capsule resists erosion longer, but once breached causes labyrinthine fistula
  • Cummings Otolaryngology, p. 1143

Summary Flowchart

Cholesteatoma matrix expansion
          │
          ├── Physical: Sac grows along paths of least resistance
          │     (Prussak space → aditus → antrum → mastoid → tegmen/labyrinth/skull base)
          │
          └── Biochemical bone destruction:
                │
                ├── Bacteria (LPS) + cholesteatoma products
                │       ↓
                ├── Inflammation → TNF-α, IL-1, IL-6
                │       ↓
                ├── RANKL on T-cells/stromal cells → RANK on osteoclast precursors
                │       ↓
                ├── Osteoclast activation → acid phosphatase + cathepsins
                │       → demineralize + digest bone collagen
                │
                ├── MMPs from epithelium → degrade extracellular matrix
                │   Neutral collagenase → strips osteoid → exposes bone
                │
                └── Keratin extrusion → foreign body granuloma → amplifies cycle
  • Cummings Otolaryngology, p. 1131-1165
  • Scott-Brown's Otorhinolaryngology, Vol 2, p. 767-793
  • Shambaugh Surgery of the Ear, p. 2051-2097

when does we reconstruct the attic in cholesteatoma disease when it is medaial or lateral to ossicles?

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching the Web

attic reconstruction cholesteatoma lateral medial ossicles scutum when to reconstruct surgery

Reading Web Page

https://sydneyearendoscopy.com/wp-content/uploads/2015/07/ee…

Finding Sources
I have enough from the textbooks and literature to give a thorough, structured answer. Let me now synthesize this carefully.

Attic Reconstruction in Cholesteatoma: When and Why

This is fundamentally a question about two separate reconstructive goals that get confused. Let me break it down clearly.

First, Understand the Anatomy: What Is the "Attic"?

The attic (epitympanum) is the space above the tympanic membrane. It has:
  • A lateral wall = the scutum (the bony lateral attic wall, part of the EAC superior wall)
  • A medial wall = the tegmen, facial nerve, and otic capsule structures
  • Contents = the head of malleus, body and short process of incus
The cholesteatoma's relationship to the ossicles -- lateral vs. medial -- determines not just what structures are destroyed, but what kind of reconstruction is required.

The Two Types and Their Position Relative to Ossicles

TypeOriginPositionStructures Destroyed First
Pars flaccida (attic) cholesteatomaPars flaccida retraction into Prussak spaceLateral to ossiclesScutum eroded; ossicles displaced medially
Pars tensa (posterosuperior) cholesteatomaPosterior/posterosuperior marginal perforationMedial to ossiclesLong process of incus + stapes eroded; ossicles displaced laterally
This positional difference is not academic -- it directly determines the surgical approach and what needs to be reconstructed.

Pars Flaccida (Lateral to Ossicles): Attic/Scutum Reconstruction

What is destroyed: The scutum (lateral attic bony wall) is eroded. The ossicles may be displaced medially but are sometimes still intact, particularly in early disease.
The reconstructive need: Once the cholesteatoma is removed, there is a bony defect in the lateral attic wall (scutum defect). If this is not reconstructed, the tympanic membrane has nothing to retract against, and a new retraction pocket forms -- which is the most common cause of recurrence.
When to reconstruct the attic (scutum):
  • After complete removal of the cholesteatoma, the scutum defect must be reconstructed in almost all canal-wall-up (CWU) approaches
  • The goal is to restore the lateral bony buttress so the tympanic membrane/pars flaccida cannot re-retract
  • This is done at the primary surgery or at second-look surgery depending on disease extent
Materials used for scutum reconstruction (scutumplasty):
  1. Tragal cartilage with perichondrium -- most popular; rigid, resistant to resorption, good for defects up to ~3 mm
  2. Cortical bone pate (crushed mastoid bone mixed with blood)
  3. Temporalis fascia alone -- less rigid, higher retraction/recurrence risk
  4. Calcium phosphate ceramics / hydroxyapatite -- synthetic option
Key condition for successful attic reconstruction: The malleus handle must be preserved (to support the cartilage graft) and Eustachian tube function must be good (without adequate ventilation, any reconstruction will fail due to persistent negative pressure).

Pars Tensa (Medial to Ossicles): Ossiculoplasty, Not Scutum Repair

What is destroyed: The ossicular chain -- specifically the long process of the incus and stapes superstructure -- because the sac is medial to and wrapped around the ossicles. The scutum is often partially intact or eroded only posteriorly.
The reconstructive need: The primary problem here is conductive hearing loss from ossicular erosion, not a scutum defect. Reconstruction means ossiculoplasty (rebuilding the ossicular chain), not lateral attic wall repair.
Ossicular reconstruction options:
  • Incus interposition -- reshaped removed incus placed between malleus and stapes head (if stapes suprastructure intact = Type III tympanoplasty equivalent)
  • PORP (Partial Ossicular Replacement Prosthesis) -- from stapes head to tympanic membrane/malleus, when incus is gone but stapes suprastructure present
  • TORP (Total Ossicular Replacement Prosthesis) -- from footplate to tympanic membrane, when stapes suprastructure also eroded
  • Staged reconstruction -- if disease was extensive or infected, leave the middle ear with a Silastic sheet and reconstruct at a second-look operation (6-12 months later)
Critical surgical note for medial disease: When the matrix is densely adherent to the stapes footplate, it is often safer to leave a small piece of matrix on the footplate at the first operation rather than risk a perilymph leak (which would cause SNHL). A second-stage procedure then removes the residual and reconstructs hearing.

The Decision Framework: Lateral vs. Medial

Cholesteatoma position relative to ossicles
         │
         ├── LATERAL to ossicles (Pars flaccida / Prussak space)
         │      │
         │      ├── Scutum eroded → ATTIC (SCUTUM) RECONSTRUCTION needed
         │      │      Material: cartilage > bone pate > fascia
         │      │
         │      └── If ossicles also eroded → ossiculoplasty ALSO needed
         │
         └── MEDIAL to ossicles (Pars tensa / posterosuperior)
                │
                ├── Incus long process / stapes eroded → OSSICULOPLASTY needed
                │      (PORP or TORP depending on stapes status)
                │
                └── Scutum less commonly affected → attic repair less critical
                    (posterior attic wall may need repair if eroded posteriorly)

The Bigger Picture: Why Attic Reconstruction Matters for Recurrence

The most important reason to reconstruct the scutum in pars flaccida disease is to address the physiopathology that created the cholesteatoma in the first place:
  1. Eustachian tube dysfunction → negative middle ear pressure
  2. Thinned, unsupported pars flaccida is sucked medially → retraction pocket
  3. Keratin accumulates → cholesteatoma
If you remove the cholesteatoma but leave the scutum defect open, the same retraction mechanism recurs, creating a new cholesteatoma. Scutum reconstruction physically blocks this. Recurrence from inadequate scutum reconstruction is the main cause of surgical failure in canal-wall-up atticotomy procedures.
"The recurrence consists in a new dangerous tympanic retraction pocket caused by inadequate reconstruction of the scutum and tympanic loss of substance, inducing persistence of the physiopathologic process of middle ear depression."
  • Marchioni et al., Otolaryngol Clin N Am 2013

Summary Table

SituationPositionWhat to ReconstructTiming
Pars flaccida, early (scutum eroded, ossicles intact)LateralScutum only (cartilage/bone pate)Primary surgery
Pars flaccida, advanced (ossicles also eroded)LateralScutum + ossiculoplasty (PORP/TORP)Scutum at primary; ossiculoplasty at primary or second-look
Pars tensa (ossicles eroded, scutum intact)MedialOssiculoplasty (PORP/TORP)Primary if safe; otherwise staged
Matrix on stapes footplate (any type)MedialLeave matrix; second-look ossiculoplastyStaged (to avoid perilymph leak)
Canal wall down (open cavity)AnyNo scutum repair needed; cavity obliteration optionalPrimary surgery

why is there 4k notch or boilers notch seen in pta in noise induced hearing loss

Finding Sources
Finding Sources
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.

Search for clinical images of 4kHz notch in PTA audiograms

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.